Biomedical Engineering Reference
In-Depth Information
145. Foster S, Duvall CL, Crownover EF et al (2010) Intracellular delivery of a protein antigen
with an endosomal-releasing polymer enhances CD8 T-cell production and prophylactic
vaccine efficacy. Bioconjug Chem 21:2205-2212
146. Yoshikawa T, Okada N, Oda A et al (2008) Development of amphiphilic
g
-PGA-nanoparticle
based tumor vaccine: potential of the nanoparticulate cytosolic protein delivery carrier.
Biochem Biophys Res Commun 366:408-413
147. Panyam J, Zhou WZ, Prabha S et al (2002) Rapid endo-lysosomal escape of poly(dl-lactide-co-
glycolide) nanoparticles: implications for drug and gene delivery. FASEB J 16:1217-1226
148. Uto T, Wang X, Akagi T et al (2009) Improvement of adaptive immunity by antigen-carrying
biodegradable nanoparticles. Biochem Biophys Res Commun 379:600-604
149. Hamasaki T, Uto TA et al (2010) Modulation of gene expression related to Toll-like receptor
signaling in dendritic cells by poly(
g
-glutamic acid) nanoparticles. Clin Vaccine Immunol
17:748-756
150. Wang X, Uto T, Akagi T et al (2007) Induction of potent CD8
+
T-cell responses by novel
biodegradable nanoparticles carrying human immunodeficiency virus type 1 gp120. J Virol
81:10009-10016
151. Wang X, Uto T, Akagi T et al (2008) Poly(
g
-glutamic Acid) nanoparticles as an efficient
antigen delivery and adjuvant system: potential for an anti-AIDS vaccine. J Med Virol
80:11-19
152. Okamoto S, Yoshii H, Akagi T et al (2007) Influenza hemagglutinin vaccine with poly
(
g
-glutamic acid) nanoparticles enhances the protection against influenza virus infection
through both humoral and cell-mediated immunity. Vaccine 25:8270-8278
153. Okamoto S, Matsuura M, Akagi T et al (2009) Poly(
g
-glutamic acid) nano-particles com-
bined with mucosal influenza virus hemagglutinin vaccine protects against influenza virus
infection in mice. Vaccine 27:5896-5905
154. Okamoto S, Yoshii H, Ishikawa T et al (2008) Single dose of inactivated Japanese encepha-
litis vaccine with poly(
g
-glutamic acid) nanoparticles provides effective protection from
Japanese encephalitis virus. Vaccine 26:589-594
155. Matsuo K, Yoshikawa T, Oda A et al (2007) Efficient generation of antigen-specific cellular
immunity by vaccination with poly(
g
-glutamic acid) nanoparticles entrapping endoplasmic
reticulum-targeted peptides. Biochem Biophys Res Commun 362:1069-1072
156. Yoshikawa T, Okada N, Oda A et al (2008) Nanoparticles built by self-assembly of am
phiphilic poly(
g
-glutamic acid) can deliver antigens to antigen-presenting cells with high
efficiency: A new tumor-vaccine carrier for eliciting effector T cells. Vaccine 26:1303-1313
157. Yamaguchi S, Tatsumi T, Takehara T et al (2010) EphA2-derived peptide vaccine with
amphiphilic poly(gamma-glutamic acid) nanoparticles elicits an anti-tumor effect against
mouse liver tumor. Cancer Immunol Immunother 59:759-767
158. Akagi T, Higashi M, Kaneko T et al (2005) In vitro enzymatic degradation of nanoparticles
prepared from hydrophobically-modified poly(
g
-glutamic acid). Macromol Biosci 5:598-602
159. Akagi T, Higashi M, Kaneko T et al (2006) Hydrolytic and enzymatic degradation of
nanoparticles based on amphiphilic poly(
g
-glutamic acid)-
graft
-L-phenylalanine copolymer.
Biomacromolecules 7:297-303
160. Akagi T, Baba M, Akashi M (2007) Preparation of nanoparticles by the self-organization of
polymers consisting of hydrophobic and hydrophilic segments: potential applications. Poly-
mer 48:6729-6747
161. Kim H, Akagi T, Akashi M (2010) Preparation of CpG ODN-encapsulated anionic poly
(amino acid) nanoparticles for gene delivery. Chem Lett 39:278-279
162. Raghuvanshi RS, Katare YK, Lalwani K et al (2002) Improved immune response from
biodegradable polymer particles entrapping tetanus toxoid by use of different immunization
protocol and adjuvants. Int J Pharm 245:109-121
163. Ataman-Onal Y, Munier S, Gan´e A et al (2006) Surfactant-free anionic PLA nanoparticles
coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in
various animal models. J Control Release 112:175-185
